Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma

Present and Future Molecular Testing of Lung Carcinoma

(2014) Sanja Dacic et al.   ADVANCES IN ANATOMIC PATHOLOGY

High-grade lung adenocarcinomas with micropapillary and/or solid patterns

(2014) Vicente Morales-Oyarvide et al.   CURRENT OPINION IN PULMONARY MEDICINE

Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivoeffects on migration capacity and tumor growth

(2013) Carolina Belmar-Lopez et al.   BMC Medicine

CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro

(2013) Qiong Li et al.   JOURNAL OF MOLECULAR HISTOLOGY

New Treatment Options for Lung Adenocarcinoma - in View of Molecular Background

(2013) Nora Bittner et al.   PATHOLOGY & ONCOLOGY RESEARCH

Mesenchymal Stem Cells for Anti-Cancer Drug Delivery

(2013) Darinka Gjorgieva et al.   Recent Patents on Anti-Cancer Drug Discovery

Genes and Pathology of Non-Small Cell Lung Carcinoma

(2013) Shingo Sakashita et al.   SEMINARS IN ONCOLOGY

New methods for inducing the differentiation of amniotic-derived mesenchymal stem cells into motor neuron precursor cells

(2013) Wei Hu et al.   TISSUE & CELL

Classification of Lung Cancer: Proposals for Change?

(2012) Keith M. Kerr   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer

(2012) Miaomiao Yang et al.   EUROPEAN JOURNAL OF CANCER

Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification

(2011) P. E. Van Schil et al.   EUROPEAN RESPIRATORY JOURNAL

Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

(2010) S. P. Kerkar et al.   CANCER RESEARCH

The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells

(2009) Q Huang et al.   CANCER GENE THERAPY

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

(2009) T. S. Bekaii-Saab et al.   MOLECULAR CANCER THERAPEUTICS